Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Balo's Concentric Sclerosis: An Update and Comprehensive Literature Review Publisher Pubmed



Amini Harandi A1 ; Esfandani A1 ; Pakdaman H1 ; Abbasi M1 ; Sahraian MA2
Authors

Source: Reviews in the Neurosciences Published:2018


Abstract

Balo's concentric sclerosis (BCS) is considered a variant of multiple sclerosis characterized by concentric lamella of alternating demyelinated and partially myelinated tissues. It is a rare and a relatively acute condition. Attacks may proceed rapidly over weeks or months, typically without remission, like Marburg's variant, resulting in death or severe disability. However, the majority of cases have a more benign, self-limiting course with spontaneous remission. Magnetic resonance imaging is a primary imaging modality in the diagnosis of BCS. Treatment with intense immunosuppression may be indicated in patients with more aggressive form. New reports reveal more evidence regarding the pathophysiology and treatment strategies. © 2018 Walter de Gruyter GmbH, Berlin/Boston 2018.
Related Docs
View other Related Docs
1. Tumefactive Multiple Sclerosis Variants: Report of Two Cases of Schilder and Balo Diseases, Iranian Journal of Child Neurology (2017)
2. Concomitant Multiple Sclerosis and Another Autoimmune Disease: Does the Clinical Course Change?, Clinical Neurology and Neurosurgery (2016)
3. Comparison of Phase Sensitive Inversion Recovery Mri With T2w-Tse and Stir in the Detection of Cervical Multiple Sclerosis Lesions, Iranian Journal of Radiology (2019)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (5)
Abdolreaza Naser Moghadasi (5)
Other Related Docs
4. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab, Acta neurologica Taiwanica (2020)
5. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Developed Two Days After the Injection of Rituximab, Acta Neurologica Taiwanica (2020)
6. Emerging Tumefactive Ms After Switching Therapy From Interferon-Beta to Fingolimod: A Case Report, Multiple Sclerosis and Related Disorders (2015)
7. Introduction to the Neuroimmunology of Multiple Sclerosis, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)
8. The Role of the Cerebellum in Multiple Sclerosis, Cerebellum (2015)
9. Seroprevalence of Nmo-Igg Antibody in Neuromyelitis Optica (Nmo) and Its Specificity in Differentiating Nmo From Other Demyelinating Diseases With Overlap Symptoms: An Iranian Experience, Iranian Journal of Allergy# Asthma and Immunology (2015)
10. A Comprehensive Review on the Treatment Approaches of Multiple Sclerosis: Currently and in the Future, Inflammation Research (2019)
11. Aggressive Course of Cognitive Impairment in Multiple Sclerosis: A New Term for the Management of Patients, Journal of Clinical Neuroscience (2020)
12. Monoclonal Antibodies in Multiple Sclerosis Treatment, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)
13. Comparison of Phase-Sensitive Inversion Recovery and Conventional Magnetic Resonance Imaging for Detection of Cortical Plaques in Ms Patients, Iranian Journal of Radiology (2021)
14. Demyelination With Preferential Mag Loss: A Complex Message From Ms Paraffin Blocks, Journal of the Neurological Sciences (2018)
15. Mri Features and Disability in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Neuroradiology (2024)
16. The Role of the Brain in the Treatment of Multiple Sclerosis As a Connectomopathy, Medical Hypotheses (2020)
17. Translational Neuroimmunology, Volume 8: Multiple Sclerosis, Translational Neuroimmunology: Multiple Sclerosis: Volume 8 (2023)
18. Multiple Sclerosis Pathogenesis: Missing Pieces of an Old Puzzle, Reviews in the Neurosciences (2019)
19. Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path, Multiple Sclerosis: A Mechanistic View (2016)
20. Safety and Effectiveness Assessment of Intravenous Immunoglobulin in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis, Medical Journal of the Islamic Republic of Iran (2016)